It is a dual agonist of GLP-1 and GIP receptors to help regulate blood sugar levels and reduce appetite to improve glycemic control and support weight loss in patients with chronic conditions
It is commonly referenced in in vitro research examining peptide stability, molecular signaling behavior, and gastrointestinal pathway investigation
OR GCGR OR GLUCAGON OR (INCRETIN
Clinical efficacy: where CT-388 stands K-Dense Web curated placebo-controlled weight loss data from peer-reviewed publications (STEP 1-4, SURMOUNT-1-4, retatrutide Phase 2, CT-388 Phase 2) and applied a critical methodological filter: only Standard-design, Non-T2D trials were used for cross-drug comparisons
Even now trying to play a professional sport, it was something that I feel like even I felt like, OK, I dont want to do this because it is a shortcut or its is like a quick way out. But it actually isnt and theres something that I feel personally that my body was missing in particular after having two kids, I wasnt able to be at a weight that was healthy for me. Williams said she wanted to tell folks of her weight-loss journey to help push back against the stigma that using a GLP-1 is lazy or provides a shortcut
